Risk factors associated with abandonment of care in retinoblastoma: analysis of 692 patients from 10 countries.
Child health (paediatrics)
Epidemiology
Neoplasia
Public health
Retina
Journal
The British journal of ophthalmology
ISSN: 1468-2079
Titre abrégé: Br J Ophthalmol
Pays: England
ID NLM: 0421041
Informations de publication
Date de publication:
22 11 2023
22 11 2023
Historique:
received:
21
01
2022
accepted:
04
09
2022
medline:
24
11
2023
pubmed:
17
9
2022
entrez:
16
9
2022
Statut:
epublish
Résumé
Rates of care abandonment for retinoblastoma (RB) demonstrate significant geographical variation; however, other variables that place a patient at risk of abandoning care remain unclear. This study aims to identify the risk factors for care abandonment across a multinational set of patients. A prospective, observational study of 692 patients from 11 RB centres in 10 countries was conducted from 1 January 2019 to 31 December 2019. Multivariate logistic regression was used to identify risk factors associated with higher rates of care abandonment. Logistic regression showed a higher risk of abandoning care based on country (high-risk countries include Bangladesh (OR=18.1), Pakistan (OR=45.5) and Peru (OR=9.23), p<0.001), female sex (OR=2.39, p=0.013) and advanced clinical stage (OR=4.22, p<0.001). Enucleation as primary treatment was not associated with a higher risk of care abandonment (OR=0.59, p=0.206). Country, advanced disease and female sex were all associated with higher rates of abandonment. In this analysis, enucleation as the primary treatment was not associated with abandonment. Further research investigating cultural barriers can enable the building of targeted retention strategies unique to each country.
Sections du résumé
BACKGROUND
Rates of care abandonment for retinoblastoma (RB) demonstrate significant geographical variation; however, other variables that place a patient at risk of abandoning care remain unclear. This study aims to identify the risk factors for care abandonment across a multinational set of patients.
METHODS
A prospective, observational study of 692 patients from 11 RB centres in 10 countries was conducted from 1 January 2019 to 31 December 2019. Multivariate logistic regression was used to identify risk factors associated with higher rates of care abandonment.
RESULTS
Logistic regression showed a higher risk of abandoning care based on country (high-risk countries include Bangladesh (OR=18.1), Pakistan (OR=45.5) and Peru (OR=9.23), p<0.001), female sex (OR=2.39, p=0.013) and advanced clinical stage (OR=4.22, p<0.001). Enucleation as primary treatment was not associated with a higher risk of care abandonment (OR=0.59, p=0.206).
CONCLUSION
Country, advanced disease and female sex were all associated with higher rates of abandonment. In this analysis, enucleation as the primary treatment was not associated with abandonment. Further research investigating cultural barriers can enable the building of targeted retention strategies unique to each country.
Identifiants
pubmed: 36113955
pii: bjo-2022-321159
doi: 10.1136/bjo-2022-321159
pmc: PMC10017370
mid: NIHMS1853621
doi:
Types de publication
Observational Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1818-1822Subventions
Organisme : NCI NIH HHS
ID : K08 CA232344
Pays : United States
Informations de copyright
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Br J Ophthalmol. 2009 Jan;93(1):38-9
pubmed: 18838414
Lancet. 2003 Aug 30;362(9385):706-8
pubmed: 12957095
Pediatr Blood Cancer. 2008 Nov;51(5):639-42
pubmed: 18668516
J Pediatr Hematol Oncol. 2017 Jul;39(5):e249-e253
pubmed: 28538507
Cancer Treat Rev. 2010 Jun;36(4):277-85
pubmed: 20231056
Br J Ophthalmol. 2010 Nov;94(11):1432-6
pubmed: 20733021
J Pediatr Ophthalmol Strabismus. 2018 May 1;55(3):182-188
pubmed: 29257183
Ophthalmology. 2021 Sep;128(9):1369-1371
pubmed: 33508429
PLoS One. 2014 Feb 21;9(2):e89102
pubmed: 24586527
Pediatr Blood Cancer. 2013 May;60(5):771-5
pubmed: 23303533
Br J Ophthalmol. 2009 Sep;93(9):1129-31
pubmed: 19704035
Lancet Oncol. 2008 Aug;9(8):721-9
pubmed: 18672210
Arch Dis Child. 2014 Jul;99(7):609-14
pubmed: 24681695
PLoS One. 2016 Oct 13;11(10):e0163090
pubmed: 27736871
Pediatr Blood Cancer. 2008 Jan;50(1):160-2
pubmed: 17120241
Ocul Oncol Pathol. 2019 Jan;5(1):1-7
pubmed: 30675470
Psychooncology. 2010 Apr;19(4):361-7
pubmed: 19434599
Oncogene. 2018 Mar;37(12):1551-1560
pubmed: 29321667
Pediatr Blood Cancer. 2012 Apr;58(4):545-50
pubmed: 21910211
Pediatrics. 2008 Sep;122(3):e763-70
pubmed: 18762512
J Clin Oncol. 2019 Nov 1;37(31):2875-2882
pubmed: 31536438
Pediatr Blood Cancer. 2011 Mar;56(3):341-8
pubmed: 21225909
Br J Ophthalmol. 2015 Jul;99(7):937-42
pubmed: 25583281
Pediatr Blood Cancer. 2007 Dec;49(7):941-6
pubmed: 17252565
Oncology (Williston Park). 2007 Jun;21(7):809-20; discussion 820, 823-4
pubmed: 17722742
Pediatr Blood Cancer. 2007 Nov;49(6):817-9
pubmed: 17009236
JAMA Oncol. 2020 May 1;6(5):685-695
pubmed: 32105305
CA Cancer J Clin. 2017 Mar;67(2):93-99
pubmed: 28094848
Int J Cancer. 2021 Feb 15;148(4):895-904
pubmed: 32875569
Arch Dis Child. 2010 Jan;95(1):20-5
pubmed: 19679573